Appearance of a BRAF Mutation Conferring Resistance to Crizotinib in Non–Small Cell Lung Cancer Harboring Oncogenic ROS1 Fusion

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of thoracic oncology 2018-04, Vol.13 (4), p.e66-e69
Hauptverfasser:	Watanabe, Junko, Furuya, Naoki, Fujiwara, Yutaka
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - genetics Crizotinib - pharmacology Crizotinib - therapeutic use Female Humans Lung Neoplasms - drug therapy Lung Neoplasms - genetics Mutation Protein-Tyrosine Kinases - genetics Protein-Tyrosine Kinases - metabolism Proto-Oncogene Proteins - genetics Proto-Oncogene Proteins - metabolism Proto-Oncogene Proteins B-raf - genetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!